Vimarsana
Biggest News Aggregation in the World

Page 4 - Pardes Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pardes Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pardes Bioscience Today - Breaking & Trending Today

Pardes Biosciences Appoints Thomas G. Wiggans to CEO and - Vimarsana News

Pardes Biosciences Appoints Thomas G. Wiggans to CEO and

Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple...

Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board - Vimarsana News

Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board

02.03.2022 - Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple successful acquisitions. His expertise will be beneficial to Pardes as the company rapidly ... Seite 1

Pardes Biosciences nets $199 million in COVID-19 pill race - Vimarsana News

Pardes Biosciences nets $199 million in COVID-19 pill race

The Carlsbad startup is in early clinical trials for an experimental antiviral oral treatment for COVID-19, akin to Tamiflu for influenza.

Carlsbad's Pardes Biosciences nets $199M in SPAC deal to keep pace in the COVID-19 pill race - Vimarsana News

Carlsbad's Pardes Biosciences nets $199M in SPAC deal to keep pace in the COVID-19 pill race

Startup is in early clinical trials for an experimental antiviral oral treatment for COVID-19, akin to Tamiflu for influenza.